Xponance’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Buy |
9,719
+399
| +4% | +$13K | ﹤0.01% | 1120 |
|
|
2025
Q1 | $352K | Buy |
9,320
+415
| +5% | +$15.7K | ﹤0.01% | 1044 |
|
|
2024
Q4 | $729K | Buy |
8,905
+1,052
| +13% | +$86.1K | 0.01% | 834 |
|
|
2024
Q3 | $897K | Buy |
7,853
+939
| +14% | +$107K | 0.01% | 733 |
|
|
2024
Q2 | $522K | Buy |
6,914
+465
| +7% | +$35.1K | 0.01% | 901 |
|
|
2024
Q1 | $441K | Buy |
6,449
+777
| +14% | +$53.1K | ﹤0.01% | 980 |
|
|
2023
Q4 | $356K | Buy |
5,672
+163
| +3% | +$10.2K | ﹤0.01% | 1025 |
|
|
2023
Q3 | $281K | Buy |
5,509
+97
| +2% | +$4.95K | ﹤0.01% | 1052 |
|
|
2023
Q2 | $270K | Buy |
+5,412
| New | +$270K | ﹤0.01% | 1072 |
|